JP2019528063A5 - - Google Patents

Download PDF

Info

Publication number
JP2019528063A5
JP2019528063A5 JP2019508929A JP2019508929A JP2019528063A5 JP 2019528063 A5 JP2019528063 A5 JP 2019528063A5 JP 2019508929 A JP2019508929 A JP 2019508929A JP 2019508929 A JP2019508929 A JP 2019508929A JP 2019528063 A5 JP2019528063 A5 JP 2019528063A5
Authority
JP
Japan
Prior art keywords
body fluid
fluid sample
cfdna
amount
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019508929A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019528063A (ja
JP7109424B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/047372 external-priority patent/WO2018035340A1/en
Publication of JP2019528063A publication Critical patent/JP2019528063A/ja
Publication of JP2019528063A5 publication Critical patent/JP2019528063A5/ja
Application granted granted Critical
Publication of JP7109424B2 publication Critical patent/JP7109424B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019508929A 2016-08-17 2017-08-17 体液に基づくセルフリーDNA(cfDNA)アッセイを通して臓器損傷状態を査定するための新規のイムノプローブに基づく方法 Active JP7109424B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662376299P 2016-08-17 2016-08-17
US62/376,299 2016-08-17
PCT/US2017/047372 WO2018035340A1 (en) 2016-08-17 2017-08-17 A novel immunoprobe-based method to assess organ injury status through a biofluid-based cell-free dna (cfdna) assay

Publications (3)

Publication Number Publication Date
JP2019528063A JP2019528063A (ja) 2019-10-10
JP2019528063A5 true JP2019528063A5 (enExample) 2020-10-15
JP7109424B2 JP7109424B2 (ja) 2022-07-29

Family

ID=61197090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019508929A Active JP7109424B2 (ja) 2016-08-17 2017-08-17 体液に基づくセルフリーDNA(cfDNA)アッセイを通して臓器損傷状態を査定するための新規のイムノプローブに基づく方法

Country Status (7)

Country Link
US (7) US11124824B2 (enExample)
EP (2) EP3500687A4 (enExample)
JP (1) JP7109424B2 (enExample)
CN (2) CN117965692A (enExample)
AU (1) AU2017313138B2 (enExample)
CA (1) CA3033650A1 (enExample)
WO (1) WO2018035340A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
BR112013020220B1 (pt) 2011-02-09 2020-03-17 Natera, Inc. Método para determinar o estado de ploidia de um cromossomo em um feto em gestação
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
EP2946345B1 (en) 2013-01-17 2024-04-03 Personalis, Inc. Methods and systems for genetic analysis
US20180173846A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
US11479812B2 (en) 2015-05-11 2022-10-25 Natera, Inc. Methods and compositions for determining ploidy
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
RU2760913C2 (ru) 2016-04-15 2021-12-01 Натера, Инк. Способы выявления рака легкого
US11506655B2 (en) 2016-07-29 2022-11-22 Streck, Inc. Suspension composition for hematology analysis control
JP7109424B2 (ja) 2016-08-17 2022-07-29 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 体液に基づくセルフリーDNA(cfDNA)アッセイを通して臓器損傷状態を査定するための新規のイムノプローブに基づく方法
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
ES2991437T3 (es) 2017-10-19 2024-12-03 Streck Llc Composiciones para la regulación de la hemólisis y la coagulación y la estabilización de vesículas extracelulares
US12084720B2 (en) 2017-12-14 2024-09-10 Natera, Inc. Assessing graft suitability for transplantation
US12024738B2 (en) 2018-04-14 2024-07-02 Natera, Inc. Methods for cancer detection and monitoring
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US12234509B2 (en) * 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
EP3905881A1 (en) * 2019-01-04 2021-11-10 QIAGEN GmbH Urine stabilization
EP4632078A2 (en) * 2019-01-24 2025-10-15 Illumina, Inc. Methods and systems for monitoring organ health and disease
EP4055610A4 (en) 2019-11-05 2023-11-29 Personalis, Inc. ESTIMATION OF TUMOR PURITY FROM SINGLE SAMPLES
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders
EP4263383A4 (en) 2020-12-17 2024-10-23 Nephrosant, Inc. KITS FOR STABILIZATION OF URINE SAMPLES
CA3226436A1 (en) * 2021-07-23 2023-01-26 Megan E. Mcnamara Use of circulating cell-free methylated dna to detect tissue damage
EP4413580A4 (en) 2021-10-05 2025-08-13 Personalis Inc PERSONALIZED TESTS FOR PERSONALIZED CANCER MONITORING
WO2024057280A1 (en) 2022-09-16 2024-03-21 Illumina Cambridge Limited Nanoparticle with polynucleotide binding site and method of making thereof
WO2025076525A1 (en) * 2023-10-06 2025-04-10 Neutrolis, Inc. Biomarker and precision therapy for inflammatory disease

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0821041B2 (ja) 1988-06-01 1996-03-04 横河電機株式会社 プリント基板cadの部品シンボル作成方法
US5849517A (en) 1991-05-08 1998-12-15 Streck Laboratories, Inc. Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same
JPH0821041A (ja) 1994-07-07 1996-01-23 Ig Tech Res Inc 瓦棒葺屋根の改修構造
EP0807689B1 (en) 1994-12-29 2003-08-13 Eiken Kagaku Kabushiki Kaisha Method of cell detection
JPH1021041A (ja) * 1996-06-28 1998-01-23 Matsushita Electric Ind Co Ltd 操作パネル
US7537889B2 (en) * 2003-09-30 2009-05-26 Life Genetics Lab, Llc. Assay for quantitation of human DNA using Alu elements
US20090280479A1 (en) * 2005-05-27 2009-11-12 John Wayne Cancer Institute Use of free circulating dna for diagnosis, prognosis, and treatment of cancer funding
US20110300608A1 (en) 2007-09-21 2011-12-08 Streck, Inc. Nucleic acid isolation in preserved whole blood
JP2010017178A (ja) 2008-06-11 2010-01-28 Sumitomo Chemical Co Ltd Dnaを定量又は検出する方法
EP3290530B1 (en) 2009-02-18 2020-09-02 Streck Inc. Preservation of cell-free nucleic acids
US8404444B2 (en) 2009-02-25 2013-03-26 Diacarta Llc Method for predicting the level of damage to cells by measuring free circulating Alu nucleic acid
US20110027771A1 (en) 2009-07-31 2011-02-03 Artemis Health, Inc. Methods and compositions for cell stabilization
WO2011057184A1 (en) 2009-11-09 2011-05-12 Streck, Inc. Stabilization of rna in and extracting from intact cells within a blood sample
JP5763098B2 (ja) 2009-12-20 2015-08-12 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
WO2012108538A1 (ja) * 2011-02-10 2012-08-16 国立大学法人 長崎大学 急性肺損傷診断方法
JP5214042B2 (ja) 2012-02-03 2013-06-19 アンリツ株式会社 光素子パッケージの製造方法
US10472679B2 (en) * 2012-05-15 2019-11-12 Cornell University Non-invasive method of diagnosing renal fibrosis
US10233508B2 (en) * 2012-08-21 2019-03-19 Qiagen Gmbh Virus particle stabilisation and method for isolating viral nucleic acids
US20150225712A1 (en) * 2012-08-21 2015-08-13 Qiagen Gmbh Method for isolating nucleic acids from a formaldehyde releaser stabilized sample
WO2014074501A1 (en) * 2012-11-06 2014-05-15 Quest Diagnostics Investments Incorporated Molecular markers for diagnosis of acute cellular rejection and acute tubular necrosis
KR20160004265A (ko) 2013-03-15 2016-01-12 이뮤코 쥐티아이 다이아그노스틱스, 아이엔씨. 무세포 dna를 이용하는 신장 상태의 평가를 위한 방법 및 조성물
WO2014146780A1 (en) * 2013-03-18 2014-09-25 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
US20160376652A1 (en) * 2013-09-06 2016-12-29 Immucor Gti Diagnostics, Inc. Compositions and methods for diagnosis and prediction of solid organ graft rejection
WO2015159293A2 (en) * 2014-04-14 2015-10-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. A method and kit for determining the tissue or cell origin of dna
ES2692393T3 (es) 2014-04-24 2018-12-03 Euroclone Spa Método de diagnóstico in vitro para cáncer por medio de ADN circulante libre de células
CA2954576C (en) 2014-07-09 2020-08-11 Daniel ENDERLE Methods for isolating microvesicles and extracting nucleic acids from biological samples
EP3497232A1 (en) 2016-08-12 2019-06-19 Streck, Inc. Molecular reference controls
JP7109424B2 (ja) 2016-08-17 2022-07-29 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 体液に基づくセルフリーDNA(cfDNA)アッセイを通して臓器損傷状態を査定するための新規のイムノプローブに基づく方法

Similar Documents

Publication Publication Date Title
JP2019528063A5 (enExample)
WO2022271820A1 (en) Spatial detection of sars-cov-2 using templated ligation
Moesker et al. Human bocavirus infection as a cause of severe acute respiratory tract infection in children
Nicot et al. Diversity of hepatitis E virus genotype 3
JP2008249727A5 (enExample)
CN111455114B (zh) SARS-CoV-2的高通量检测试剂盒
CN107541563B (zh) 一种用于早期诊断、预测脓毒血症并发急性肾损伤的分子标记物、试剂盒及应用
CN111187860A (zh) 新型冠状病毒多重pcr快速检测试剂盒
CN105506182B (zh) 一种猪病毒性腹泻病毒5重rt-pcr检测试剂盒
JP2015530868A5 (enExample)
CN103866050B (zh) 猪流行性腹泻病毒荧光定量pcr检测方法及其引物
Simanavicius et al. Detection of rat hepatitis E virus, but not human pathogenic hepatitis E virus genotype 1–4 infections in wild rats from Lithuania
CN102791886A (zh) 区分fecv和fipv的工具和方法
CN106435029A (zh) 猫传染性腹膜炎病毒检测用引物组和试剂盒及其检测方法
Park et al. First detection and characterization of hepatitis E virus (Rocahepevirus ratti) from urban Norway rats (Rattus norvegicus) in the Republic of Korea
CN104711369A (zh) 高致病性猪蓝耳病病毒的检测引物、探针及检测方法
CN103805717B (zh) 一种用于检测I型和IV型马疱疹病毒的双重Eva Green实时荧光定量PCR检测试剂盒及其应用
CN104774918A (zh) 基于实时荧光pcr的il28b基因多态性检测试剂盒
CN110029160B (zh) 一种基于血浆lncRNA组合物的肺结核病疗效评价试剂盒及其用途
Yahyavi et al. Nucleic acid‐based electrochemical biosensor for detection of influenza B by gold nanoparticles
CN102344970A (zh) 同时检测人cmv和bk病毒dna的引物序列及定量检测试剂盒
CN107699638A (zh) 一种检测猫杯状病毒的方法
CN111690772A (zh) 一种新冠病毒核酸检测试剂盒、制备方法及应用
CN105112568A (zh) 基于焦磷酸测序的鲤春病毒血症病毒检测试剂盒
CN111411169A (zh) 用于恒温扩增检测麻疹病毒的核酸序列、试剂盒及方法和应用